Regarding Mastorino et al.'s ‘Efficacy of anti‐IL‐23 and anti‐IL‐17 after adalimumab failure in psoriatic patients’

Sebastian YuJames Cheng‐Chung Wei2026-02-032026-02-032023-07-2610.1111/jdv.19334https://scholars.csmu.edu.tw/handle/123456789/4797Regarding Mastorino et al.'s ‘Efficacy of anti‐IL‐23 and anti‐IL‐17 after adalimumab failure in psoriatic patients’journal-article